Request for Covid-19 Impact Assessment of this Report
The United States Artemisinin Antimalarial Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Artemisinin Antimalarial Drugs market, reaching US$ million by the year 2028. As for the Europe Artemisinin Antimalarial Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Artemisinin Antimalarial Drugs players cover Novartis, Sanofi, Ajanta, and Cipla, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin Antimalarial Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Artesunate
Dihydroartemisinin
Artemether
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Prevention
Treatment
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
Sanofi
Ajanta
Cipla
Ipca
Guilin Medicine
GlaxoSmithKline
Mylan Labs
Roche
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artemisinin Antimalarial Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Artemisinin Antimalarial Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Artemisinin Antimalarial Drugs by Country/Region, 2017, 2022 & 2028
2.2 Artemisinin Antimalarial Drugs Segment by Type
2.2.1 Artesunate
2.2.2 Dihydroartemisinin
2.2.3 Artemether
2.3 Artemisinin Antimalarial Drugs Sales by Type
2.3.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Artemisinin Antimalarial Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Artemisinin Antimalarial Drugs Sale Price by Type (2017-2022)
2.4 Artemisinin Antimalarial Drugs Segment by Application
2.4.1 Prevention
2.4.2 Treatment
2.4.3 Other
2.5 Artemisinin Antimalarial Drugs Sales by Application
2.5.1 Global Artemisinin Antimalarial Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Artemisinin Antimalarial Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Artemisinin Antimalarial Drugs Sale Price by Application (2017-2022)
3 Global Artemisinin Antimalarial Drugs by Company
3.1 Global Artemisinin Antimalarial Drugs Breakdown Data by Company
3.1.1 Global Artemisinin Antimalarial Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Artemisinin Antimalarial Drugs Sales Market Share by Company (2020-2022)
3.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Artemisinin Antimalarial Drugs Revenue by Company (2020-2022)
3.2.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Artemisinin Antimalarial Drugs Sale Price by Company
3.4 Key Manufacturers Artemisinin Antimalarial Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinin Antimalarial Drugs Product Location Distribution
3.4.2 Players Artemisinin Antimalarial Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Artemisinin Antimalarial Drugs by Geographic Region
4.1 World Historic Artemisinin Antimalarial Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Artemisinin Antimalarial Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Geographic Region
4.2 World Historic Artemisinin Antimalarial Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Artemisinin Antimalarial Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Artemisinin Antimalarial Drugs Annual Revenue by Country/Region
4.3 Americas Artemisinin Antimalarial Drugs Sales Growth
4.4 APAC Artemisinin Antimalarial Drugs Sales Growth
4.5 Europe Artemisinin Antimalarial Drugs Sales Growth
4.6 Middle East & Africa Artemisinin Antimalarial Drugs Sales Growth
5 Americas
5.1 Americas Artemisinin Antimalarial Drugs Sales by Country
5.1.1 Americas Artemisinin Antimalarial Drugs Sales by Country (2017-2022)
5.1.2 Americas Artemisinin Antimalarial Drugs Revenue by Country (2017-2022)
5.2 Americas Artemisinin Antimalarial Drugs Sales by Type
5.3 Americas Artemisinin Antimalarial Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Antimalarial Drugs Sales by Region
6.1.1 APAC Artemisinin Antimalarial Drugs Sales by Region (2017-2022)
6.1.2 APAC Artemisinin Antimalarial Drugs Revenue by Region (2017-2022)
6.2 APAC Artemisinin Antimalarial Drugs Sales by Type
6.3 APAC Artemisinin Antimalarial Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Artemisinin Antimalarial Drugs by Country
7.1.1 Europe Artemisinin Antimalarial Drugs Sales by Country (2017-2022)
7.1.2 Europe Artemisinin Antimalarial Drugs Revenue by Country (2017-2022)
7.2 Europe Artemisinin Antimalarial Drugs Sales by Type
7.3 Europe Artemisinin Antimalarial Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artemisinin Antimalarial Drugs by Country
8.1.1 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type
8.3 Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs
10.3 Manufacturing Process Analysis of Artemisinin Antimalarial Drugs
10.4 Industry Chain Structure of Artemisinin Antimalarial Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinin Antimalarial Drugs Distributors
11.3 Artemisinin Antimalarial Drugs Customer
12 World Forecast Review for Artemisinin Antimalarial Drugs by Geographic Region
12.1 Global Artemisinin Antimalarial Drugs Market Size Forecast by Region
12.1.1 Global Artemisinin Antimalarial Drugs Forecast by Region (2023-2028)
12.1.2 Global Artemisinin Antimalarial Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artemisinin Antimalarial Drugs Forecast by Type
12.7 Global Artemisinin Antimalarial Drugs Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Artemisinin Antimalarial Drugs Product Offered
13.1.3 Novartis Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Artemisinin Antimalarial Drugs Product Offered
13.2.3 Sanofi Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Ajanta
13.3.1 Ajanta Company Information
13.3.2 Ajanta Artemisinin Antimalarial Drugs Product Offered
13.3.3 Ajanta Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Ajanta Main Business Overview
13.3.5 Ajanta Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Artemisinin Antimalarial Drugs Product Offered
13.4.3 Cipla Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Ipca
13.5.1 Ipca Company Information
13.5.2 Ipca Artemisinin Antimalarial Drugs Product Offered
13.5.3 Ipca Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Ipca Main Business Overview
13.5.5 Ipca Latest Developments
13.6 Guilin Medicine
13.6.1 Guilin Medicine Company Information
13.6.2 Guilin Medicine Artemisinin Antimalarial Drugs Product Offered
13.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Guilin Medicine Main Business Overview
13.6.5 Guilin Medicine Latest Developments
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Information
13.7.2 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Offered
13.7.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GlaxoSmithKline Main Business Overview
13.7.5 GlaxoSmithKline Latest Developments
13.8 Mylan Labs
13.8.1 Mylan Labs Company Information
13.8.2 Mylan Labs Artemisinin Antimalarial Drugs Product Offered
13.8.3 Mylan Labs Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mylan Labs Main Business Overview
13.8.5 Mylan Labs Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Artemisinin Antimalarial Drugs Product Offered
13.9.3 Roche Artemisinin Antimalarial Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
14 Research Findings and Conclusion
Table 1. Artemisinin Antimalarial Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Artemisinin Antimalarial Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Artesunate
Table 4. Major Players of Dihydroartemisinin
Table 5. Major Players of Artemether
Table 6. Global Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 7. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Artemisinin Antimalarial Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Artemisinin Antimalarial Drugs Sale Price by Type (2017-2022) & (US$/G)
Table 11. Global Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 12. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Artemisinin Antimalarial Drugs Revenue by Application (2017-2022)
Table 14. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Artemisinin Antimalarial Drugs Sale Price by Application (2017-2022) & (US$/G)
Table 16. Global Artemisinin Antimalarial Drugs Sales by Company (2020-2022) & (KG)
Table 17. Global Artemisinin Antimalarial Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Artemisinin Antimalarial Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Artemisinin Antimalarial Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Artemisinin Antimalarial Drugs Sale Price by Company (2020-2022) & (US$/G)
Table 21. Key Manufacturers Artemisinin Antimalarial Drugs Producing Area Distribution and Sales Area
Table 22. Players Artemisinin Antimalarial Drugs Products Offered
Table 23. Artemisinin Antimalarial Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Artemisinin Antimalarial Drugs Sales by Geographic Region (2017-2022) & (KG)
Table 27. Global Artemisinin Antimalarial Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Artemisinin Antimalarial Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Artemisinin Antimalarial Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Artemisinin Antimalarial Drugs Sales by Country/Region (2017-2022) & (KG)
Table 31. Global Artemisinin Antimalarial Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Artemisinin Antimalarial Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Artemisinin Antimalarial Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)
Table 35. Americas Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 39. Americas Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 41. Americas Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Artemisinin Antimalarial Drugs Sales by Region (2017-2022) & (KG)
Table 43. APAC Artemisinin Antimalarial Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Artemisinin Antimalarial Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Artemisinin Antimalarial Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 47. APAC Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 49. APAC Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)
Table 51. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 55. Europe Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 57. Europe Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2017-2022) & (KG)
Table 59. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Type (2017-2022) & (KG)
Table 63. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Application (2017-2022) & (KG)
Table 65. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Artemisinin Antimalarial Drugs
Table 67. Key Market Challenges & Risks of Artemisinin Antimalarial Drugs
Table 68. Key Industry Trends of Artemisinin Antimalarial Drugs
Table 69. Artemisinin Antimalarial Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Artemisinin Antimalarial Drugs Distributors List
Table 72. Artemisinin Antimalarial Drugs Customer List
Table 73. Global Artemisinin Antimalarial Drugs Sales Forecast by Region (2023-2028) & (KG)
Table 74. Global Artemisinin Antimalarial Drugs Sales Market Forecast by Region
Table 75. Global Artemisinin Antimalarial Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Artemisinin Antimalarial Drugs Sales Forecast by Country (2023-2028) & (KG)
Table 78. Americas Artemisinin Antimalarial Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Artemisinin Antimalarial Drugs Sales Forecast by Region (2023-2028) & (KG)
Table 80. APAC Artemisinin Antimalarial Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Artemisinin Antimalarial Drugs Sales Forecast by Country (2023-2028) & (KG)
Table 82. Europe Artemisinin Antimalarial Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Artemisinin Antimalarial Drugs Sales Forecast by Country (2023-2028) & (KG)
Table 84. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Artemisinin Antimalarial Drugs Sales Forecast by Type (2023-2028) & (KG)
Table 86. Global Artemisinin Antimalarial Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Artemisinin Antimalarial Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Artemisinin Antimalarial Drugs Sales Forecast by Application (2023-2028) & (KG)
Table 90. Global Artemisinin Antimalarial Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Artemisinin Antimalarial Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Artemisinin Antimalarial Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Novartis Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Artemisinin Antimalarial Drugs Product Offered
Table 95. Novartis Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Sanofi Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Artemisinin Antimalarial Drugs Product Offered
Table 100. Sanofi Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Ajanta Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Ajanta Artemisinin Antimalarial Drugs Product Offered
Table 105. Ajanta Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 106. Ajanta Main Business
Table 107. Ajanta Latest Developments
Table 108. Cipla Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Cipla Artemisinin Antimalarial Drugs Product Offered
Table 110. Cipla Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 111. Cipla Main Business
Table 112. Cipla Latest Developments
Table 113. Ipca Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Ipca Artemisinin Antimalarial Drugs Product Offered
Table 115. Ipca Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 116. Ipca Main Business
Table 117. Ipca Latest Developments
Table 118. Guilin Medicine Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Guilin Medicine Artemisinin Antimalarial Drugs Product Offered
Table 120. Guilin Medicine Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 121. Guilin Medicine Main Business
Table 122. Guilin Medicine Latest Developments
Table 123. GlaxoSmithKline Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. GlaxoSmithKline Artemisinin Antimalarial Drugs Product Offered
Table 125. GlaxoSmithKline Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 126. GlaxoSmithKline Main Business
Table 127. GlaxoSmithKline Latest Developments
Table 128. Mylan Labs Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Mylan Labs Artemisinin Antimalarial Drugs Product Offered
Table 130. Mylan Labs Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 131. Mylan Labs Main Business
Table 132. Mylan Labs Latest Developments
Table 133. Roche Basic Information, Artemisinin Antimalarial Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Roche Artemisinin Antimalarial Drugs Product Offered
Table 135. Roche Artemisinin Antimalarial Drugs Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 136. Roche Main Business
Table 137. Roche Latest Developments
List of Figures
Figure 1. Picture of Artemisinin Antimalarial Drugs
Figure 2. Artemisinin Antimalarial Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinin Antimalarial Drugs Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Artemisinin Antimalarial Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Artemisinin Antimalarial Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Artesunate
Figure 10. Product Picture of Dihydroartemisinin
Figure 11. Product Picture of Artemether
Figure 12. Global Artemisinin Antimalarial Drugs Sales Market Share by Type in 2021
Figure 13. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Artemisinin Antimalarial Drugs Consumed in Prevention
Figure 15. Global Artemisinin Antimalarial Drugs Market: Prevention (2017-2022) & (KG)
Figure 16. Artemisinin Antimalarial Drugs Consumed in Treatment
Figure 17. Global Artemisinin Antimalarial Drugs Market: Treatment (2017-2022) & (KG)
Figure 18. Artemisinin Antimalarial Drugs Consumed in Other
Figure 19. Global Artemisinin Antimalarial Drugs Market: Other (2017-2022) & (KG)
Figure 20. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application in 2021
Figure 22. Artemisinin Antimalarial Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Artemisinin Antimalarial Drugs Revenue Market Share by Company in 2021
Figure 24. Global Artemisinin Antimalarial Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Artemisinin Antimalarial Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Artemisinin Antimalarial Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Artemisinin Antimalarial Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Artemisinin Antimalarial Drugs Sales 2017-2022 (KG)
Figure 29. Americas Artemisinin Antimalarial Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Artemisinin Antimalarial Drugs Sales 2017-2022 (KG)
Figure 31. APAC Artemisinin Antimalarial Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Artemisinin Antimalarial Drugs Sales 2017-2022 (KG)
Figure 33. Europe Artemisinin Antimalarial Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Artemisinin Antimalarial Drugs Sales 2017-2022 (KG)
Figure 35. Middle East & Africa Artemisinin Antimalarial Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Artemisinin Antimalarial Drugs Sales Market Share by Country in 2021
Figure 37. Americas Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2021
Figure 38. United States Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Artemisinin Antimalarial Drugs Sales Market Share by Region in 2021
Figure 43. APAC Artemisinin Antimalarial Drugs Revenue Market Share by Regions in 2021
Figure 44. China Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country in 2021
Figure 51. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Artemisinin Antimalarial Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Artemisinin Antimalarial Drugs in 2021
Figure 65. Manufacturing Process Analysis of Artemisinin Antimalarial Drugs
Figure 66. Industry Chain Structure of Artemisinin Antimalarial Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...